Candidal meningitis
ICD-10 B40.0 is a billable code used to indicate a diagnosis of candidal meningitis.
Candidal meningitis is a rare but serious fungal infection of the central nervous system caused by Candida species, most commonly Candida albicans. This condition typically occurs in immunocompromised patients, such as those with HIV/AIDS, cancer, or those undergoing immunosuppressive therapy. The infection can manifest as a result of hematogenous spread from other sites of infection, such as the bloodstream or from direct extension from adjacent structures. Symptoms may include fever, headache, neck stiffness, altered mental status, and other neurological deficits. Diagnosis is often confirmed through lumbar puncture, where cerebrospinal fluid (CSF) analysis reveals the presence of Candida organisms. Treatment typically involves antifungal therapy, with agents such as amphotericin B or fluconazole being the most commonly used. Early diagnosis and prompt treatment are crucial to improving outcomes, as candidal meningitis can lead to significant morbidity and mortality if left untreated.
Detailed history of immunocompromised conditions, laboratory results, and treatment plans.
Patients with HIV/AIDS presenting with neurological symptoms, patients with recent chemotherapy.
Ensure clear documentation of the source of infection and any prior antifungal treatments.
Neurological examination findings, imaging results, and CSF analysis.
Patients presenting with altered mental status and signs of meningitis.
Document any differential diagnoses considered and the rationale for the final diagnosis.
Used to obtain CSF for analysis in suspected meningitis cases.
Document indication for procedure, patient consent, and CSF findings.
Neurology specialists should ensure thorough documentation of neurological assessments.
Common symptoms include fever, headache, neck stiffness, altered mental status, and neurological deficits. Prompt recognition and treatment are essential.
